Targeted gene mutations define the roles of insulin and IGF-I receptors in mouse embryonic development

Journal of Pediatric Endocrinology and Metabolism

Volumn 12, Issue 4, 1999, Pages 475-485

  Accili, Domenico ^a,b   Nakae, Jun ^a   Kim, Jane J ^a   Park, Byung Chul ^a   Rother, Kristina I ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b Building 10 ^*  (United States)

Author keywords

IGF I receptor; IGF II receptor; Insulin receptor; Insulin like growth factor I (IGF I); Insulin like growth factor II (IGF II); Knockout mice; Mutations

Indexed keywords

INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

DIABETES MELLITUS; EMBRYO DEVELOPMENT; GENE MUTATION; GROWTH RETARDATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; POSTNATAL GROWTH; PRENATAL GROWTH; REVIEW;

EID: 0032768019     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1999.12.4.475     Document Type: Review

References (62)

1. Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvatore P, Asico LD, Jose PA, Taylor SI, Westphal H. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene Nat Genet 1996; 12: 106-109.
2. Joshi RL, Lamothe B, Cordonnier N, Mesbah K, Monthioux E, Jami J, Bucchini D. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J 1996; 15: 1542-1547.
3. Louvi A, Accili D, Efstratiadis A. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev Biol 1997; 189: 33-48.
4. Grupe A, Hultgren B, Ryan A, Ma YH, Bauer M, Stewart TA. Transgenic knockouts reveal a critical requirement for pancreatic beta cell glucokinase in maintaining glucose homeostasis. Cell 1995; 83: 69-78.
5. Lei KJ, Chen H, Pan CJ, Ward JM, Mosinger B Jr, Lee EJ, Westphal H, Mansfield BC, Chou JY. Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse. Nat Genet 1996; 13: 203-209.
6. Wang ND, Finegold MJ, Bradley A, Ou CN, Abdelsayed SV, Wilde MD, Taylor LR, Wilson DR, Darlington GJ. Impaired energy homeostasis in C/EBP alpha knockout mice. Science 1995; 269: 1108-1112.
7. Girard JR, Kervan A, Soufflet E, Assan R. Factors affecting the secretion of insulin and glucagon by the rat fetus. Diabetes 1973; 23: 310-317.
8. Wertheimer E, Lu SP, Backeljauw PF, Davenport ML, Taylor SI. Homozygous deletion of the human insulin receptor gene results in leprechaunism. Nat Genet 1993; 5: 71-73.
9. Psiachou H, Mitton S, Alaghband ZJ, Hone J, Taylor SI, Sinclair L. Leprechaunism and homozygous nonsense mutation in the insulin receptor gene. Lancet 1993; 342; 924.
10. Krook A, Brueton L, O'Rahilly S. Homozygous nonsense mutation in the insulin receptor gene in infant with leprechaunism [see comments]. Lancet 1993; 342: 277-278.
11. Jospe N, Kaplowitz PB, Furlanetto RW. Homozygous nonsense mutation in the insulin receptor gene of a patient with severe congenital insulin resistance: leprechaunism and the role of the insulin-like growth factor receptor. Clin Endocrinol 1996; 45: 229-235.
12. Accili D. Molecular defects of the insulin receptor gene. Diabetes Metab Rev 1995; 11: 47-62.
13. Taylor SI. Lilly Lecture: Molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes 1992; 41: 1473-1490.
14. Bier DM, Schedewie H, Larner J, Olefsky J, Rubenstein A, Fiser RH, Craig JW, Elders MJ. Glucose kinetics in leprechaunism: accelerated fasting due to insulin resistance. J Clin Endocrinol Metab 1980; 51: 988-994.
15. Backeljauw PF, Alves C, Eidson M, Cleveland W, Underwood LE, Davenport ML. Effect of intravenous insulin-like growth factor I in two patients with leprechaunism. Pediatr Res 1994; 36: 749-754.
16. Di Cola G, Cool MH, Accili D. Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors. J Clin Invest 1997; 99: 2538-2544.
17. Roach P, Zick Y, Formisano P, Accili D, Taylor SI, Gorden P. A novel human insulin receptor gene mutation uniquely inhibits insulin binding without impairing posttranslational processing. Diabetes 1994; 43: 1096-1102.
18. Herrera PL, Huarte J, Sanvito F, Meda P, Orci L, Vassalli JD. Embryogenesis of the murine endocrine pancreas: early expression of pancreatic polypeptide gene. Development 1991; 113: 1257-1265.
19. McEvoy RC, Madson KL. Pancreatic insulin-, glucagon-, and somatostatin-positive islets cell populations during the perinatal development of the rat. II. Changes in hormone content and concentration. Biol Neonate 1980; 38: 255-259.
20. Kervran A, Girard JR. Glucose induced increase of plasma insulin in the rat fetus in utero. J Endocrinol 1974; 62: 545-551.
21. Girard J, Ferre P, Pegorier JP, Duee PH. Adaptations of glucose and fatty acid metabolism during perinatal period and suckling-weaning transition. Physiol Rev 1992; 72: 507-562.
22. Pegorier JP, Prip BC, Duee PH, Girard J. Hormonal control of fatty acid oxidation during the neonatal period. Diabete Metab 1992; 18: 156-160.
23. Ferre P, Perdereau D, Leturque A, Issad T, Postic C, Coupe C, Girard J. Adaptations of glucose metabolism in white-fat adipocytes at weaning in the rat are concomitant with specific gene expression. Biochem Soc Trans 1990; 18: 857-858.
24. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igflr). Cell 1993; 75: 59-72.
25. White MF, Maron R, Kahn CR. Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells. Nature 1985; 318: 183-186.
26. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers MJ, Glasheen E, Lane WS, Pierce JH, White MF. Role of IRS-2 in insulin and cytokine signalling. Nature 1995; 377: 173-177.
27. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White MF. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 1991; 352: 73-77.
28. Lavan BE, Lane WS, Lienhard GE. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem 1997; 272: 11439-11443.
29. Lavan BE, Fantin VR, Chang ET, Lane WS, Keller SR, Lienhard GE. A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J Biol Chem 1997; 272: 21403-21407.
30. Holgado-Madruga M, Emlet DR, Moscatello DK, Godwin AK, Wong AJ. A Grb2-associated docking protein in EGF-and insulin-receptor signalling. Nature 1996; 379: 560-564.
31. Eck MJ, Dhe PS, Trub T, Nolte RT, Shoelson SE. Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell 1996; 85: 695-705.
32. Yenush L, White MF. The IRS-signalling system during insulin and cytokine action. Bioessays 1997; 19: 491-500.
33. White MF. The IRS-signalling system in insulin and cytokine action. Philos Trans R Soc Lond B Biol Sci 1996; 351: 181-189.
34. Araki E, Lipes MA, Patti ME, Bruning JC, Haag BR, Johnson RS, Kahn CR. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 1994; 372: 186-190.
35. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S, Sekihara H, Yoshioka S, Horikoshi H, Furuta Y, Ikawa Y, Kasuga M, Yazaki Y, Aizawa S. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 1994; 372: 182-186.
36. Bruning JC, Winnay J, Bonner WS, Taylor SI, Accili D, Kahn CR. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 1997; 88: 561-572.
37. Yamauchi Y, Tobe K, Tamemoto H, Kohjiro U, Kaburagi Y, Yamamoto-Honda R, Takahashi Y, Yoshizawa F, Aizawa S, Akanuma Y, Sonenberg N, Yazaki Y, Kadowaki T. Insulin signaling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice. Mol Cell Biol 1996; 16: 3074-3084.
38. Withers DJ, Sanchez-Gutierrez J, Towery H, Burks DJ, Ren J-M, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 1998; 391: 900-904.
39. Bruning JC, Winnay J, Cheatham B, Kahn CR. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells. Mol Cell Biol 1997; 17: 1513-1521.
40. Schultz GA, Hogan A, Watson AJ, Smith RM, Heyner S. Insulin, insulin-like growth factors and glucose transporters: temporal patterns of gene expression in early murine and bovine embryos. Reprod Fertil Dev 1992; 4: 361-371.
41. Tyrala EE. The infant of the diabetic mother. Obstet Gynecol Clin N Am 1996; 23: 221-241.
42. Naeye RL. Infants of diabetic mothers: A quantitative, morphologic study. Pediatrics 1965; 35: 980-988.
43. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993; 75: 73-82.
44. Ludwig T, Eggenschwiler J, Fisher P, D'Ercole AJ, Davenport ML, Efstratiadis A. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igflr null backgrounds. Dev Biol 1996; 177: 517-535.
45. DeChiara TM, Efstratiadis A, Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 1990; 345: 78-80.
46. Duvillie B, Cordonnier N, Deltour L, Dandoy-Dron F, Itier JM, Monthioux E, Jami J, Joshi RL, Bucchini D. Phenotypic alterations in insulin-deficient mutant mice. Proc Natl Acad Sci USA 1997; 94: 5137-5140.
47. Rother KI, Imai Y, Caruso M, Beguinot F, Formisano P, Accili D. Evidence that 1RS-2 phosphorylation is required for insulin action in hepatocytes. J Biol Chem 1998; 273: 17491-17497.
48. Hone J, Accili D, Psiachou H, Alghband ZJ, Mitton S, Wertheimer E, Sinclair L, Taylor SI. Homozygosity for a null allele of the insulin receptor gene in a patient with leprechaunism. Hum Mutat 1995; 6: 17-22.
49. Lauro D, Kido Y, Castle AL, Zarnowski MJ, Hayashi H, Ebina Y, Accili D. Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue. Nat Genet 1998; 20: 294-298.
50. Sevel D. A reappraisal of the development of the eyelids. Eye 1988; 2: 123-129.
51. Widdowson EM. Chemical composition of newly born mammals. Nature 1950; 166: 626-628.
52. Voldsgaard P, Kryger-Baggesen N, Lisse I. Agenesis of pancreas. Acta Paediatr 1994; 83: 791-793.
53. Wright NM, Metzger DL, Borowitz SM, Clarke WL. Permanent neonatal diabetes mellitus and pancreatic exocrine insufficiency resulting from congenital pancreatic agenesis [letter]. Am J Dis Child 1993; 147: 607-609.
54. Cinti S, Eberbach S, Castellucci M, Accili D. Lack of insulin receptors affects the formation of white adipose tissue in mice. A morphological and ultrastructural analysis. Diabetologia 1998; 41: 171-177.
55. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, Borenstein N, Dove W. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 1993; 75: 631-639.
56. Bonyadi M, Rusholme SAB, Cousins FM, Su HC, Biron CA, Farrall M, Akhurst RJ. Mapping of a major genetic modifier of embryonic lethality in TGFb1 knock-out mice. Nat Genet 1997; 15: 207-211.
57. Gu H, Zou YR, Rajewsky K. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 1993; 73: 1155-1164.
58. Kuhn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science 1995; 269: 1427-1429.
59. Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, Accili D, Goodyear LJ, Kahn CR. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 1998; 2: 559-569.
60. Dietrich WF, Copeland NG, Gilbert DJ, Miller JC, Jenkins NA, Lander ES. Mapping the mouse genome: current status and future prospects. Proc Natl Acad Sci USA 1995; 92: 10849-10853.
61. Groot PC, Moen CJ, Dietrich W, Stoye JP, Lander ES, Demant P. The recombinant congenic strains for analysis of multigenic traits: genetic composition. FASEB J 1992; 6: 2826-2835.
62. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994; 265: 2037-2048.